Duchenne muscular dystrophy laboratory findings: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Duchenne muscular dystrophy}} {{CMG}}; {{AE}} {{Fs}} ==Overview== An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of...") |
No edit summary |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Laboratory findings consistent with the diagnosis of Duchenne [[muscular dystrophy]] include increased level of [[CPK]], [[transaminases]], and [[aldolase]]. | |||
Laboratory findings consistent with the diagnosis of [ | |||
[ | |||
==Laboratory Findings== | ==Laboratory Findings== | ||
Laboratory findings consistent with the diagnosis of Duchenne [[muscular dystrophy]] include:<ref name="pmid22451200">{{cite journal |vauthors=Mendell JR, Shilling C, Leslie ND, Flanigan KM, al-Dahhak R, Gastier-Foster J, Kneile K, Dunn DM, Duval B, Aoyagi A, Hamil C, Mahmoud M, Roush K, Bird L, Rankin C, Lilly H, Street N, Chandrasekar R, Weiss RB |title=Evidence-based path to newborn screening for Duchenne muscular dystrophy |journal=Ann. Neurol. |volume=71 |issue=3 |pages=304–13 |date=March 2012 |pmid=22451200 |doi=10.1002/ana.23528 |url=}}</ref><ref name="pmid21149430">{{cite journal |vauthors=McMillan HJ, Gregas M, Darras BT, Kang PB |title=Serum transaminase levels in boys with Duchenne and Becker muscular dystrophy |journal=Pediatrics |volume=127 |issue=1 |pages=e132–6 |date=January 2011 |pmid=21149430 |doi=10.1542/peds.2010-0929 |url=}}</ref><ref name="Okinaka1961">{{cite journal|last1=Okinaka|first1=S.|title=Serum Creatine Phosphokinase|journal=Archives of Neurology|volume=4|issue=5|year=1961|pages=520|issn=0003-9942|doi=10.1001/archneur.1961.00450110050006}}</ref><ref name="SoltanBlanchaer1959">{{cite journal|last1=Soltan|first1=Hubert C.|last2=Blanchaer|first2=Marcel C.|title=Activity of serum aldolase and lactic dehydrogenase in patients affected with duchenne muscular dystrophy and in their immediate relatives|journal=The Journal of Pediatrics|volume=54|issue=1|year=1959|pages=27–33|issn=00223476|doi=10.1016/S0022-3476(59)80033-0}}</ref> | |||
*Increased CK | |||
**If a physician suspects DMD after examining the boy they will use a [[Creatine kinase|CPK]] ([[creatine phosphokinase]]) test to determine if the [[muscles]] are damaged. | |||
**In DMD patients [[Creatine kinase|CPK]] leaks out of the [[muscle cell]] into the [[blood]], and the high level of [[CPK]] in these patients is an evidence of [[muscle]] damage. | |||
**These [[Patient|patients]] may have [[CPK]] as high as 15,000 to 35,000iu/l (normal = 60iu/l). | |||
*Increased [[aldolase]] levels | |||
*[[Aspartate transaminase]] ([[Aspartate transaminase|AST]]) | |||
*[[Alanine transaminase]] ([[ALT]]) | |||
[ | NOTE: After few years, as the [[disease]] progress and [[muscle cells]] are replaced by [[fat]], these [[enzyme]]<nowiki/>s will be back to their normal levels. | ||
*[ | |||
*[ | |||
==References== | ==References== | ||
Latest revision as of 15:46, 1 May 2019
|
Duchenne muscular dystrophy Microchapters |
|
Differentiating Duchenne muscular dystrophy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Duchenne muscular dystrophy laboratory findings On the Web |
|
American Roentgen Ray Society Images of Duchenne muscular dystrophy laboratory findings |
|
Risk calculators and risk factors for Duchenne muscular dystrophy laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
Laboratory findings consistent with the diagnosis of Duchenne muscular dystrophy include increased level of CPK, transaminases, and aldolase.
Laboratory Findings
Laboratory findings consistent with the diagnosis of Duchenne muscular dystrophy include:[1][2][3][4]
- Increased CK
- If a physician suspects DMD after examining the boy they will use a CPK (creatine phosphokinase) test to determine if the muscles are damaged.
- In DMD patients CPK leaks out of the muscle cell into the blood, and the high level of CPK in these patients is an evidence of muscle damage.
- These patients may have CPK as high as 15,000 to 35,000iu/l (normal = 60iu/l).
- Increased aldolase levels
- Aspartate transaminase (AST)
- Alanine transaminase (ALT)
NOTE: After few years, as the disease progress and muscle cells are replaced by fat, these enzymes will be back to their normal levels.
References
- ↑ Mendell JR, Shilling C, Leslie ND, Flanigan KM, al-Dahhak R, Gastier-Foster J, Kneile K, Dunn DM, Duval B, Aoyagi A, Hamil C, Mahmoud M, Roush K, Bird L, Rankin C, Lilly H, Street N, Chandrasekar R, Weiss RB (March 2012). "Evidence-based path to newborn screening for Duchenne muscular dystrophy". Ann. Neurol. 71 (3): 304–13. doi:10.1002/ana.23528. PMID 22451200.
- ↑ McMillan HJ, Gregas M, Darras BT, Kang PB (January 2011). "Serum transaminase levels in boys with Duchenne and Becker muscular dystrophy". Pediatrics. 127 (1): e132–6. doi:10.1542/peds.2010-0929. PMID 21149430.
- ↑ Okinaka, S. (1961). "Serum Creatine Phosphokinase". Archives of Neurology. 4 (5): 520. doi:10.1001/archneur.1961.00450110050006. ISSN 0003-9942.
- ↑ Soltan, Hubert C.; Blanchaer, Marcel C. (1959). "Activity of serum aldolase and lactic dehydrogenase in patients affected with duchenne muscular dystrophy and in their immediate relatives". The Journal of Pediatrics. 54 (1): 27–33. doi:10.1016/S0022-3476(59)80033-0. ISSN 0022-3476.